Resources from the same session
1261O - Neoadjuvant nivolumab (N) + ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial
Presenter: Mark Awad
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA56 - Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
Presenter: Jonathan Spicer
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
LBA60 - Stereotactic body radiation therapy with sequential immunochemotherapy as neoadjuvant therapy in resectable non-small cell lung cancer
Presenter: Ze-rui Zhao
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1291O - Radiotherapy boost to 74 Gy based on FDG-PET at 42 Gy of radiochemotherapy (RCT) in patients with inoperable stage III non-small cell lung cancer (RTEP7 – IFCT 1401): A prospective multicentre, open-label, randomised, controlled trial
Presenter: Gerard Zalcman
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA60 and 1291O
Presenter: Rafal Dziadziuszko
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
LBA98 - Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial
Presenter: Claudia Proto
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA92 - Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
Presenter: Luis Paz-Ares
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA98 and LBA92
Presenter: Pilar Garrido Lopez
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast